Shanmuga Hospital IPO Details
Shanmuga Hospital IPO Summary
Shanmuga Hospital IPO opens for subscription on 13 Feb 2025 and closes on 17 Feb 2025.The IPO will be listed on BSE with the tentative listing date set for 20 Feb 2025.
Shanmuga Hospital IPO price band has been fixed at ₹54 – ₹54 per share. The face value is ₹10 per share with a lot size of 2000.
Shanmuga Hospital IPO total issue size comprises 38,18,000 shares (aggregating up to ₹20.62 Cr). This includes a fresh issue of 38,18,000 shares (aggregating up to ₹20.62 Cr). Pre-issue shareholding stands at 97,95,000, which will increase to 1,36,13,000 post-issue.
Shanmuga Hospital IPO carries a ₹3 (5.56%) GMP, reflecting investor sentiment.
Shanmuga Hospital IPO Lot Size :Retail Minimum is 1 lot (2,000 shares) amounting to ₹108,000. Retail Maximum is 1 lot (2,000 shares) amounting to ₹108,000. HNI Minimum is 2 lots (4,000 shares) amounting to ₹216,000.
The Lead Managers for Shanmuga Hospital IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Finshore Management Services Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For SME (Small and Medium-sized Enterprise) IPOs, a Market Maker is appointed to ensure liquidity and stability for the stock once it is listed. They do this by continuously quoting bid and ask prices, ensuring there is a market for the shares. The appointed market maker for this IPO is Black Fox Financial. You can analyze their track record by checking the Market Maker Performance Summary report.
For detailed information, Refer to the Shanmuga Hospital Limited RHP.
Shanmuga Hospital IPO Details
Shanmuga Hospital IPO Subscription
Shanmuga Hospital IPO Application Wise Breakup
Shanmuga Hospital IPO Dates
- 13 Feb 2025Opening dateOpen
- 17 Feb 2025Closing dateClose
- 18 Feb 2025Allotment Date Allotment
- 19 Feb 2025Initiation of RefundsRefund
- 19 Feb 2025Credit of SharesCredit
- 20 Feb 2025Listing dateListing
Shanmuga Hospital IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 2000 | ₹108,000 |
| Retail Maximum | 1 | 2000 | ₹108,000 |
| HNI Minimum | 2 | 4000 | ₹216,000 |
Shanmuga Hospital IPO Reservation
Promoter Holding
Documents
Shanmuga Hospital IPO Valuations
Shanmuga Hospital Financial Information
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
| Assets | 36.53 | 33.92 | 23.05 | 10.65 | ||||||||||||||||||||||||||||||||||||
| Revenue | 24.83 | 43.39 | 39.5 | 41.47 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 2.39 | 5.26 | 4.76 | 6.72 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 19.53 | 17.13 | 11.82 | 7.06 | ||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 9.73 | 7.34 | 11.74 | 6.98 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 9.76 | 9.02 | 7.65 | |||||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
About Shanmuga Hospital IPO
Incorporated in 2020, Shanmuga Hospital Limited is a Multispecialty Hospital.
Shanmuga Hospital is equipped with advanced healthcare technology and having 151 bed capacity, it addresses the community’s medical needs, serving patients from nearby regions.
Accredited by NABH and NABL, the hospital is dedicated to providing high-quality healthcare services, including prevention, treatment, and rehabilitation.
Located at 51/24 Saradha College Road, Salem, Tamil Nadu, the hospital spans 45,311 square feet across two blocks and three floors, offering IPD and OPD services with a dedicated team.
Hospital Units:
- Shanmuga Pharmacy & Diagnostics:
The hospital operates Shanmuga Pharmacy, providing medications to OPD and IPD patients. Shanmuga Diagnostics offers reliable pathology services for accurate medical evaluations and treatment planning. - Shanmuga Clinics:
The hospital extends services through Shanmuga Clinics, providing specialized consultations and treatments in Salem. Critical patients are transferred to the main hospital for advanced care when necessary.
Services: Oncology, General Surgery, Orthopaedics, Cardiology,General Medicine, Paediatrics & Neonatology, Neurology, Endocrinology & Diabetes Department, Plastic Surgery, Respiratory Medicine.
As on August 31, 2024, the hospital had 72 doctors, out of whom 9 doctors were Resident Doctors, 7 Junior Doctors, 28 Senior Consulting Doctors and 28 Consulting Visiting Doctors.
Competitive Strengths:
- Oncology Presence
- Rich experience of promoters of over four decades
- Cost Affordable to Regional Population
- Specialized Equipment like LINAC, CATHLAB, MRI, MODULAR OT
- Tie-up with Government and Private Insurance Companies
Strength Of Shanmuga Hospital IPO
1. Established and proven track record.
2. Leveraging the experience of our Promoters.
3. Experienced management team and a motivated and efficient work force.
4. Cordial relations with our customers.
5. Quality Assurance & Control.
Risk Of Shanmuga Hospital IPO
1. Our Company, Directors, Promoters and Group Companies are parties to certain legal proceedings. Any adverse decision in such proceedings may have a material adverse effect on our business, results of operations and financial condition
2. Our Company has limited operating history, and therefore investors may not be able to assess our prospects on the basis of historical results.
3. We are highly dependent on our healthcare professionals, including doctors, nurses that we engage on a consultancy basis, and our business and financial results could be impacted if we are not able to attract and retain such healthcare professionals.
4. Our Company is yet to place orders for medical equipment proposed to be installed at our hospital. Any delay in placing orders or procurement of such equipment may delay the schedule of implementation and possibly increase the cost of commencing operations.
5. We generate certain revenues from the arrangements with government sponsored health schemes, any adverse change in these regulations/government policies related to such schemes may adversely affect our business, results of operations, cash flows and prospects.
6. Delay in receipt of payment from our patients / customers may affect our cash flows, which may, in turn affect our financial condition and results of operations.
7. Our indebtedness and the conditions and restrictions imposed by our financing arrangements may limit our ability to grow our business and adversely impact our business.
8. Changes in healthcare laws, rules and regulations may materially adversely affect our business
9. Our Company had negative cash flow in recent fiscals, details of which are given below. Sustained negative cash flow could adversely impact our business, financial condition and results of operations.
10. There are certain instances of delays in the past with ROC/Statutory Authorities.
Objectives Shanmuga Hospital IPO
- Funding Capital Expenditure towards Purchase of additional Medical Equipment
- General Corporate Purposes
Company Contact Details
Shanmuga Hospital Limited
51/24,
Saradha College Road,
Salem, 636007
Phone: +91 427 2706674
Email: cs@smrft.org
Website: http://www.shanmugahospital.com/
Registrar Contact Details
Shanmuga Hospital FAQs
The Shanmuga Hospital IPO is a SME public issue comprising 3818000 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹20.62 Cr. The issue price has been fixed at ₹54 per equity share, and the minimum application size is 2000 shares.
The IPO opens for subscription on 13 Feb 2025, and closes on 17 Feb 2025.
Integrated Registry Management Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the BSE
As of now, the current GMP stands at ₹3 (5.56%).
Quick Links
Comments
